Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001641172-25-005245
Filing Date
2025-04-17
Accepted
2025-04-17 16:32:41
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-17

Document Format Files

Seq Description Document Type Size
1 ars.pdf ARS 1967473
  Complete submission text file 0001641172-25-005245.txt   2711255
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41184 | Film No.: 25847802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)